| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |